Agile Thinking

Share this post

User's avatar
Agile Thinking
Largest Hormone Study Ever Run On Medicare Age Ladies Taking Estrogen Therapies.
Hormones

Largest Hormone Study Ever Run On Medicare Age Ladies Taking Estrogen Therapies.

Hot off the press! By our NIH and National Library of Medicine.

devaki berkson's avatar
devaki berkson
Apr 14, 2024
∙ Paid
21

Share this post

User's avatar
Agile Thinking
Largest Hormone Study Ever Run On Medicare Age Ladies Taking Estrogen Therapies.
10
2
Share

Bottom line: Estrogen therapies, if your provider knows what they are doing - alas, these are not taught in med schools presently - are safe and protective for most ladies 65 years and older. They live longer healthier lives with less of specific cancers, especially breast! Less heart disease! Less cognitive decline. Topical and vaginal were often better than oral. They recommend “low dose” but this was if you were still taking progestins. Though their information on progesterone was baffling. PS: Your provider can learn the “honest/hard science” in’s and out’s in our upcoming Everything Hormones course, April 26th, 27th online. Includes in-depth thyroid analysis and the “King Solomon serum parameter “reverse T3”!

__________________

I have been watching this study for a while. Studies are “parked” in the peer review process until they are given the blessings that they are correct. Then if found to be correct, they are officially published in “peer reviewed journals”.

I have been sharing at hormone conferences the “Pre-print” info since spring of 2023.

Earlier I called it the 7 million study, as the NIH and the National Library of Congress looked at detailed health records of 7 million women.

Now, it’s been extended to have looked at 10 million American women.

The author’s (our own NIH and Nat’l Library of Medicine) meticulously tracked effects of estrogen therapies (looked at how they get into the body, the dosing, etc.) on older women’s lives.

You could call this the 10 million NIH Estrogen Therapy Medicare Study.

Who did this study?

Affiliation

  • Lister Hill National Center for Biomedical Communications,

  • National Library of Medicine,

  • US National Institutes of Health, Bethesda, MD.

This study looked at 10 million US women over 65 years of age.

They looked at who was on estrogen therapy. How they got it into their bodies. And how estrogen therapies effected specific “end points”: Longevity, risk of 5 cancers (breast, ovarian, uterine, lung and colorectal), risk of severe heart issues or cognitive issues, and longevity.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Dr. Devaki Lindsey Berkson
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share